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The aim of this study was to assess the patients’ use of inhaled short acting bronchodilators as rescue 
therapy during a 4-week study period. In this study an electronic metered-dose inhaler compliance monitor 
(MDI-CM) was used to measure the time and date of actuations of the device and this information was then 
compared with the patients’ self reporting diary card (DC). Salbutamol canisters were used in the compliance 
monitor. The study was approved by the local ethics committee, and written informed consent was obtained from 
all patients. Patients aged 18 years and over who were either receiving, or in the investigators opinion required, 
inhaled salbutamol on a PRN basis were enrolled for a 4-week monitoring phase during which all rescue 
salbutamol used was obtained from the MDI-CM. Patients were recording their use of salbutamol in the 
DC each morning and evening. There was a 2-week follow-up period following completion of the monitoring 
phase or withdrawal from the study. Forty-four patients were enrolled and 35 patients completed the study. The 
mean age (range) was 43 (20-76) years and mean FEV, 2.32 (0.74.0) 1, with male:female ratio of 19:25. 
Comparison of MDI-CM and DC recordings showed patients fell into three categories: (1) patients who used 
rescue salbutamol appropriately and whose MDI-CM and DC recordings matched closely; (2) patients who used 
rescue salbutamol for acute relief but whose MDI-CM and DC recordings did not correlate and (3) patients 
whose use of rescue salbutamol was inappropriate or erratic according to the MDI-CM but whose DC indicated 
good compliance. This category of patients include those who ‘dumped’ all their salbutamol before attending 
clinic appointments.There was no siginificant difference in the demographic details or the severity of disease in 
the three groups. 
Recorded use of ‘rescue’ bronchodilator is frequently used as an indicator of efficacy for new anti-asthma 
therapies. This study comparing electronic data monitoring and remembered rescue salbutamol highlights the 
potential errors that can occur without accurate recording systems. 
RESPIR. MED. (1998) 92, 1188-1190 
Introduction 
In clinical studies investigating the efficiency of prophy- 
lactic asthma therapy it is common practice to assess the 
patients’ use of inhaled bronchodilators as rescue therapy 
and the data obtained are used as a measurement of 
efficacy. The quality of this data depends on the accuracy of 
the patients’ self-reporting of bronchodilator use which is 
usually in the form of a diary card rather than objective 
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measurement. There are various ways to measure com- 
pliance, like measuring the drug in the blood or saliva (l-3) 
measuring the inhaled drug in the urine (4,5), or using 
electromechanical counters for various inhaler devices 
(6-10). 
In this study an electronic metered dose inhaler (MDI) 
compliance monitor (CM) was used to measure the time 
and date of actuations of the device and this information 
was then compared with the self-reported diary card (DC). 
The primary objective of the study was to compare patients’ 
self-reporting of PRN salbutamol use on a daily diary 
card with actual use as recorded by the MD1 compliance 
monitor, but the secondary objective was to gain a greater 
understanding of the functionality of the MDI-CM in 
patient use. Salbutamol canisters were used in the 
MDI-CM as this drug is widely used by asthma sufferers on 
a PRN basis. 
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Patients and Methods 
The study was a single centre open study and patients first 
entered a 4 week monitoring phase. During this time all 
rescue salbutamol used was supplied from the MDI-CM, 
which was tested for validation. There was a 2 week 
follow-up period for any patient with an unresolved adverse 
event following completion of the monitoring phase or 
withdrawal from the study. Patients were told that 
MDI-CM contained a ‘counter’ but not that all actuations 
would be date and time stamped. 
After receiving ethics committee’s approval adult 
patients with airways obstruction fulfiling the following 
inclusion criteria were asked to participate in the study: (a) 
patients aged 18 years and over, able and willing to give 
written informed consent; (b) patients who were receiving 
or in the investigators opinion required inhaled salbutamol 
on a PRN basis via a pressurized metered dose inhaler; (c) 
patients who were able to understand and complete a daily 
diary card to record the number of puffs of inhaled sal- 
butamol used each day and at night and (d) patients who 
were able to correctly use a metered dose inhaler as assessed 
by the investigators. 
The following patients were excluded from the study: (a) 
females who were pregnant or lactating or who were likely 
to become pregnant during the study (these were excluded 
as a precaution, however, females of child bearing potential 
were included if in the investigators opinion they were 
taking adequate contraceptives); (b) patients with evidence 
of alcohol or drug abuse; (c) patients with hypersensitivity 
to salbutamol and (d) patients who were previously entered 
into the study. 
Forty-four patients were enrolled into the study, out of 
which nine patients either did not return the diary card or 
compliance monitor, so data was evaluable for 35 patients. 
Nineteen patients were male and 25 female with mean age 
43 (20-76) years and mean FEV, 2.2 (0.7-4.0) 1. 
Results 
Patients fell into three groups. 
Group 1 
Patients [mean age 44 (21-76) years, mean FEV, 2.38 
(0.74) 1 and M:F ratio 1:30] who used rescue salbutamol 
appropriately and whose DC and MDI-CM recordings 
matched closely, 18/35 (51.4%) (Fig. 1). 
Gvoup 2 
Patients [mean age 41 (22-74) years, mean FEV, 2.01(0.8- 
3.4) 1 and M:F ratio 1: l] who used rescue salbutamol for 
acute relief but whose DC and MDI-CM recordings did not 
correlate, 1 l/35 (3 1.4%) (Fig. 2). 
Gvoup 3 
Patients [mean age 52 (30-75) years, mean FEV, 2.5 (2.0- 
3.0) 1 and M:F ratio 5: l] whose use of rescue salbutamol was 
inappropriate or erratic according to the MDI-CM but 
whose DC indicated good compliance, 6/35 (17.2%) (Fig. 3). 
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FIG. 1. Patients who used rescue salbutamol appropri- 
ately and whose DC (0) and MDI-CM (w) matched 
closely. 
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FIG. 2. Patients who used rescue salbutamol for acute 
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FIG. 3. Patients whose use of rescue salbutamol was 
inappropriate according to MDI-CM (B) but whose DC 
(0) indicated good compliance. 
One patient dumped 114 actuations of MDI-CM 2 days 
prior to the clinic visit, although the DC of that patient 
showed regular entries of the use of his inhaled salbutamol; 
another patient kept neat and regular entries of inhaled 
salbutamol on DC but MDI-CM did not show the use of a 
single actuation. There were more discrepancies between 
the recorded use of inhaler on DC and MDI-CM at night 
compared to the day (Table 1). 
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TABLE 1. 
Week No. evaluable Median Range 
T 
(a) Percentage of days with salbutamol use recorded on 
DC and MDI-CM 
Daily recorded card 
1 43 86 O-100 
2 40 93 O-100 
3 40 83 O-100 
4 38 86 O-100 
MDI-CM 
1 43 51 O-100 
2 40 38 O-100 
3 40 43 O-100 
4 38 50 O-100 
(b) Percentage of nights with salbutamol use recorded on 
DC and MDI-CM 
Daily recorded card 
1 43 29 O-100 
2 40 36 O-100 
3 40 21 O-100 
4 38 0 O-100 
MCI-CM 
1 43 29 O-100 
2 40 36 O-100 
3 40 21 O-100 
4 38 28 O-100 
Discussion 
Common measures used to assess compliance with asthma 
medications include direct measures (1 l), which confirm the 
use of medication by assaying it in the blood (1,2), urine 
(4,5), or saliva (3). Indirect measures can be used with 
varying degrees of reliability, by the use of clinical judg- 
ment, self report on a diary card and electronic monitors 
(6-10). 
We used pressurized study inhalers fitted with compliance 
monitors. These were electronic devices containing a micro- 
chip that recorded the use of inhaler throughout the trial 
period. They were shower proof and had a battery life of 
18 months. The inhaler was able to withstand X-rays as 
used for security checks at airports. The MD1 compliance 
monitor had undergone validation testing. Eight volunteers 
were asked to use a total of 16 MDI-CM each, over a period 
of 1 month, on varying dosing schedules. The volunteers 
also kept daily diaries to note the number of doses taken 
and the time at which they were taken. The diary and 
compliance monitor recordings were compared. Validation 
testing showed the compliance monitors recorded to within 
+2 readings/100 (no recordings were missed) and the 
time of the recordings fell within the pre-defined limit for 
accuracy ( i 5 minutes over 1 month period). 
Although patients were told that there was a counter 
inside the inhaler, they were not aware that it could count 
the date, time and number of actuations. At the end of the 
trial all study medication was collected and the data was 
down loaded onto a computer. 
Recorded use of rescue bronchodilator is frequently used 
as an indicator of efficacy for new anti-asthma therapies, 
and we conclude that, this study comparing electronic 
monitoring and ‘remembered’ rescue salbutamol use high- 
lights the potential errors that can occur without accurate 
recording systems. 
While half the population studied showed reasonable 
correlation between diary card and compliance monitor 
recordings, the diary card data from the other half did not 
give an accurate indication of rescue salbutamol usage. 
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